Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Recovery in Sacrocolpopexy
NCT03094442Withdrawn
- Sponsor
- Cleveland Clinic
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in pelvic organ prolapse (POP) (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Quality of Recovery 40 at 6 weeks. Planned start Dec 2016; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
pelvic organ prolapse (POP)
Beyond the preview
Go deeper on NCT03094442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03094442.